Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: NeuroInvestment who wrote (1069)	3/10/2006 5:28:58 PM
From: Icebrg	Read Replies (1) \| Respond to of 1255

Harry, I am not trying to endorse Urko or his views. I just felt that it was an unnecessary prediction to make. If there are no non-refractory participants in the trial, his observation will of course fall to the ground. It was really not necessary to talk about refractory patients at all. 85 % of the Y! board's population would anyhow have been extremely happy, if he had just suggested that his contacts at the Zoo in Amsterdam are saying that the sz trial will be another slam-dunk. And most of the remaining 15 % have him probably on ignore. Erik